SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,246,000 | +49.2% | 26,483 | -8.9% | 0.36% | +22.3% |
| Q1 2020 | $2,845,000 | -32.9% | 29,080 | -11.5% | 0.29% | -6.4% |
| Q4 2019 | $4,240,000 | +56.9% | 32,855 | -8.4% | 0.31% | +53.2% |
| Q3 2019 | $2,703,000 | -55.2% | 35,882 | -9.5% | 0.20% | -51.3% |
| Q2 2019 | $6,028,000 | +21.4% | 39,668 | -4.8% | 0.42% | +32.0% |
| Q1 2019 | $4,964,000 | -0.8% | 41,649 | -9.2% | 0.32% | -12.2% |
| Q4 2018 | $5,004,000 | -36.1% | 45,852 | -5.4% | 0.36% | -16.7% |
| Q3 2018 | $7,825,000 | -52.9% | 48,449 | -61.5% | 0.43% | -54.1% |
| Q2 2018 | $16,616,000 | +70.8% | 125,707 | -4.3% | 0.94% | +74.4% |
| Q1 2018 | $9,731,000 | -4.5% | 131,334 | -28.3% | 0.54% | +11.1% |
| Q4 2017 | $10,187,000 | -12.6% | 183,091 | -28.8% | 0.49% | +2.5% |
| Q3 2017 | $11,656,000 | – | 256,970 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |